Home › Funds › PSP Research LLC › TNGX

PSP Research LLC position in TNGX

TANGO THERAPEUTICS INC · Health Care

PSP Research LLC reported holding 10,000 shares of TNGX (TANGO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$250K, representing 0.17% of its reported portfolio and ranking #19 among its reported holdings. PSP Research LLC has disclosed TNGX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)10.00K sh
Reported value held$249.50K
Portfolio Weight0.17%
First reportedQ1 2026
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's TNGX position evolved

PSP Research LLC first disclosed a stake in TNGX in Q1 2026 at 14,400 shares (US$301K). The position peaked in Q2 2026 at 10,000 shares, worth US$313K. Across 3 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 10,000 shares valued at US$250K. Notable position changes include a 31% trim in Q2 2026 (shares fell 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 14.40K $301.25K New
Q2 2026 10.00K $312.60K Reduce
Q3 2026 10.00K $249.50K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNGX and 13F data

TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 85 other funds we track also report a position in TNGX — the largest reported positions include RTW INVESTMENTS, LP (US$434.5M), Farallon Capital Management (US$383.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$383.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNGX

All TNGX fund holders →

FAQ

How long has PSP Research LLC held TNGX?

PSP Research LLC has disclosed TNGX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is PSP Research LLC's current position in TNGX?

As of Q3 2026, PSP Research LLC holds 10.00K shares of TNGX (TANGO THERAPEUTICS INC), valued at $249.50K, representing 0.17% of its reported portfolio and ranking #19.

Has PSP Research LLC been buying or selling TNGX?

In the latest 13F filing (Q3 2026), PSP Research LLC held unchanged its position in TNGX. The position peaked in Q2 2026 at 10.00K shares.

Which other funds hold TNGX?

Other major institutional holders of TNGX include RTW INVESTMENTS, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 85 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.